Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen Edge Medical CoHKSE:02675 -3.14%11 Days Payable is 29.23 as of Dec. 2025, which is 31% below its 10-year median of 42.21. GuruFocus rates HKSE:02675 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 82.89% on this metric.
The historical rank and industry rank for Shenzhen Edge Medical Co's Days Payable or its related term are showing as below:
HKSE:02675'
s Days Payable Range Over the Past 10 Years
Min: 31.43 Med: 42.21 Max: 109.58
Current: 31.43
During the past 3 years, Shenzhen Edge Medical Co's highest Days Payable was 109.58. The lowest was 31.43. And the median was 42.21.
HKSE:02675's Days Payable is ranked worse than 82.89% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.36
vs HKSE:02675: 31.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co Days Payable Chart
Shenzhen Edge Medical Co Annual Data
Trend
Dec23
Dec24
Dec25
Days Payable
109.58
42.21
36.28
Shenzhen Edge Medical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Days Payable
0.00
98.28
29.81
28.40
29.23
HKSE:02675 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Shenzhen Edge Medical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Edge Medical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shenzhen Edge Medical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Shenzhen Edge Medical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co (HKSE:02675) has a Days Payable of 29.23 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Edge Medical Co and its competitors. This is 31% below median its historical median of 42.21. Over the past decade, Shenzhen Edge Medical Co's Days Payable has ranged from 31.43 to 109.58. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #659 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 82.9%.
Is Shenzhen Edge Medical Co's Days Payable too high?
Shenzhen Edge Medical Co's current Days Payable of 29.23 is 31% below median its 10-year median of 42.21. Over the past 10 years, this metric has ranged from a low of 31.43 to a high of 109.58. The Medical Devices & Instruments industry median Days Payable is 68.36. Shenzhen Edge Medical Co's value of 29.23 is 57.2% below this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #659 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #659 out of 795 companies for Days Payable. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median Days Payable is 68.36. Shenzhen Edge Medical Co's value of 29.23 is 57.2% below this benchmark. Historically, Shenzhen Edge Medical Co's own Days Payable has ranged from 31.43 to 109.58 over the past decade. While the company's 10-year median is 42.21 vs. the industry median of 68.36, Shenzhen Edge Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.36, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current Days Payable of 29.23 is 57.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current Days Payable is 29.23, which is 31% below median its own 10-year median of 42.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (HKSE:02675) has a current Days Payable of 29.23. The current Days Payable is 29.23, which is 31% below median its 10-year median of 42.21 and 57.2% below the Medical Devices & Instruments industry median of 68.36. Shenzhen Edge Medical Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shenzhen Edge Medical Co (HKSE:02675), the current Days Payable is 29.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
11GF Score
Get the complete analysis for HKSE:02675
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02675 has been successfully added to your 
